Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares | Reuters

Part of story

Bristol Myers ends blood cancer drug partnership with Cellares

Bristol Myers Squibb terminated its partnership with cell therapy startup Cellares to expand manufacturing of its personalized blood cancer therapy, prompting Cellares to lay off 100 employees.

Aug 24, 20262 sourcesPersonalized medicine

Bristol Myers ends blood cancer drug partnership with Cellares

Other sources for this story

BioPharma Dive

Cellares, a cell therapy manufacturing specialist, to lay off 100 employees

Featured Stories

CIA Director John Ratcliffe arrives in Moscow aboard US military plane for meetings

Aug 25, 20268 sources